Compression Therapy Market by Technique, Product (Bandages, Wraps, Stockings, Tapes, Ortho Braces, Pump), Application (Varicose Vein, DVT, Lymphedema Ulcer), Distribution Channel(Hospitals, Clinics, Pharmacies, E-Commerce) - Global Forecast to 2027
Compression Therapy Market by Technique, Product (Bandages, Wraps, Stockings, Tapes, Ortho Braces, Pump), Application (Varicose Vein, DVT, Lymphedema Ulcer), Distribution Channel(Hospitals, Clinics, Pharmacies, E-Commerce) - Global Forecast to 2027
Abstract
The compression therapy market size is expected to grow from an estimated USD 3.7 billion in 2022 to USD 4.9 billion by 2027, at a CAGR of 5.5%. Rising global prevalence of diabetes, venus leg ulcer, deep vein thrombosis and rapid growth in the older population with orthopedic disorders are likely to boost the adoption of compression therapy products. Growing cases of sports injuries, favorable clinical evidence for the use of compression therapy products in the management of several diseases and new developments in compression therapy by global giants are further anticipated to support the growth of the market.
“Compression pumps segment is expected to witness the highest growth rate during the forecast period”
On the basis of product, the compression therapy market is segmented into compression bandages, compression wraps, compression stockings, compression tapes, compression pumps, compression braces, and other compression garments. Compression pumps segment is anticipated to register the highest CAGR during the forecast period. Factors such as the increasing incidence of cancer, the rising prevalence of chronic venous diseases, and the growing number of hip and knee surgeries are expected to drive the growth of the compression pumps market during the forecast period.
“varicose vein treatment segment to capture the largest market share or compression therapy market in 2021, by application
On the basis of application, the compression therapy market is segmented into varicose vein treatment, deep vein thrombosis treatment, lymphedema treatment, leg ulcer treatment, and other applications. The varicose vein treatment segment accounted for the largest share the compression therapy market in 2021. The large share of this segment is mainly driven by the increasing prevalence of varicose veins, the high preference for compression therapy as the first line of treatment for varicose veins,
” The Asia Pacific market is expected to grow at the highest CAGR during the forecast period”
The global compression therapy market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa). During the forecast period of Asia Pacific market is estimated to grow at the highest CAGR owing to the increase in patient population with diabetes, large geriatric patient pool, growing prevalence of orthopedic disorders and improved healthcare infrastructure in the region.
A breakdown of the primary participants referred to for this report is provided below:
•By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
•By Designation: C-level–10%, Director-level–14%, and Others–76%
•By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%
The major players operating in the compression therapy market are DJO, Inc. (US), BSN Medical (US), medi GmbH & Co. KG (Germany), Tactile Medical (US), SIGVARIS (Switzerland), Paul Hartmann AG (Germany), Sanyleg S.r.l. (Italy), 3M (US), ConvaTec Inc. (US), ArjoHuntleigh (Sweden), Julius Zorn GmbH (Germany), Bio Compression Systems, Inc. (US), Cardinal Health, Inc. (US), Smith & Nephew Plc (UK) and Mego Afek Ltd. (Israel).
Research Coverage
This report studies the compression therapy market based on product, technique, application, distribution channel, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the compression therapy market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the compression therapy market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the compression therapy market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Content
Table of Contents
1INTRODUCTION26
1.1STUDY OBJECTIVES26
1.2MARKET DEFINITION26
1.2.1INCLUSIONS & EXCLUSIONS27
1.3STUDY SCOPE28
1.3.1MARKETS COVERED28
1.3.2YEARS CONSIDERED29
1.4CURRENCY29
TABLE 1STANDARD CURRENCY CONVERSION RATES30
1.5LIMITATIONS30
1.6KEY MARKET STAKEHOLDERS30
1.7SUMMARY OF CHANGES30
2RESEARCH METHODOLOGY32
2.1RESEARCH DATA32
FIGURE 1RESEARCH DESIGN32
2.1.1SECONDARY DATA33
2.1.1.1Indicative list of secondary sources34
2.1.2PRIMARY DATA35
2.1.2.1Key data from primary sources36
FIGURE 2BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION36
2.2MARKET ESTIMATION METHODOLOGY37
FIGURE 3RESEARCH METHODOLOGY: HYPOTHESIS BUILDING37
2.2.1REVENUE MAPPING-BASED MARKET ESTIMATION38
2.2.2SALES/DISTRIBUTION CHANNEL-BASED MARKET ESTIMATION39
FIGURE 4MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL COMPRESSION THERAPY MARKET39
FIGURE 5CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS40
2.3RECESSION IMPACT41
2.3.1IMPACT OF RECESSION ON COMPRESSION THERAPY MARKET41
2.4DATA TRIANGULATION42
FIGURE 6DATA TRIANGULATION METHODOLOGY42
2.5RESEARCH ASSUMPTIONS43
2.6RESEARCH LIMITATIONS43
3EXECUTIVE SUMMARY44
FIGURE 7COMPRESSION THERAPY MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)44
FIGURE 8COMPRESSION THERAPY MARKET SHARE, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)45
FIGURE 9COMPRESSION THERAPY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)45
FIGURE 10COMPRESSION THERAPY MARKET SHARE, BY DISTRIBUTION CHANNEL, 2022 VS. 202746
FIGURE 11GEOGRAPHICAL SNAPSHOT OF COMPRESSION THERAPY MARKET47
4PREMIUM INSIGHTS48
4.1COMPRESSION THERAPY MARKET OVERVIEW48
FIGURE 12GROWING INCIDENCE OF SPORTS INJURIES AND FAVORABLE CLINICAL EVIDENCE TO DRIVE MARKET GROWTH48
4.2COMPRESSION THERAPY MARKET SHARE, BY PRODUCT, 2022 VS. 2027 (USD MILLION)49
FIGURE 13COMPRESSION PUMPS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD49
4.3COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)50
FIGURE 14STATIC COMPRESSION THERAPY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD50
4.4COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 (USD MILLION)51
FIGURE 15HOSPITALS & CLINICS TO ACCOUNT FOR LARGEST SHARE OF COMPRESSION THERAPY MARKET IN 202751
4.5COMPRESSION THERAPY MARKET, BY REGION, 2020–202752
FIGURE 16ASIA PACIFIC TO WITNESS FASTEST GROWTH IN MARKET DURING FORECAST PERIOD52
5MARKET OVERVIEW53
5.1INTRODUCTION53
5.2MARKET DYNAMICS53
FIGURE 17COMPRESSION THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES53
5.2.1DRIVERS54
5.2.1.1Large target patient population54
FIGURE 18GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 205055
5.2.1.2Growing incidence of sports injuries and accidents55
FIGURE 19EUROPE: ROAD DEATHS PER MILLION INHABITANTS, BY COUNTRY, 202156
5.2.1.3Increasing number of orthopedic procedures56
5.2.1.4Greater product affordability and market availability57
5.2.1.5Clinical evidence favoring adoption of compression therapy for management of target conditions57
5.2.2RESTRAINTS58
5.2.2.1Lack of universally accepted standards for compression products58
5.2.2.2Low patient compliance with compression garments58
FIGURE 20REASONS FOR NON-COMPLIANCE TO COMPRESSION THERAPY59
5.2.3OPPORTUNITIES59
5.2.3.1Growth potential offered by emerging markets59
5.2.3.2Growing patient awareness regarding benefits of compression therapy60
5.2.3.3Increased sales of off-the-shelf and online products60
5.2.4CHALLENGES60
5.2.4.1Significant adoption of alternative therapies for specific target indications60
5.2.4.2Increasing pricing pressure on market players61
5.3PORTER’S FIVE FORCES ANALYSIS61
5.3.1OVERVIEW61
TABLE 2COMPRESSION THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS62
5.3.2BARGAINING POWER OF BUYERS62
5.3.3BARGAINING POWER OF SUPPLIERS62
5.3.4THREAT FROM NEW ENTRANTS62
5.3.5THREAT FROM SUBSTITUTES62
5.3.6INTENSITY OF COMPETITIVE RIVALRY63
5.4PRICING TREND ANALYSIS63
5.4.1AVERAGE SELLING PRICE, BY PRODUCT63
TABLE 3AVERAGE PRICE OF KEY COMPRESSION THERAPY PRODUCTS, 2021 (USD)63
5.4.2AVERAGE SELLING PRICE, BY REGION64
TABLE 4REGIONAL PRICING ANALYSIS OF KEY COMPRESSION THERAPY PRODUCTS, 2021 (USD)64
5.5TECHNOLOGY ANALYSIS64
5.5.1WIRELESS BIOSENSORS64
5.5.2GARMENT MANUFACTURING TECHNOLOGIES65
5.6REGULATORY ANALYSIS66
5.6.1NORTH AMERICA66
5.6.1.1US66
TABLE 5US FDA: MEDICAL DEVICE CLASSIFICATION67
TABLE 6US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS67
5.6.1.2Canada68
TABLE 7CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS68
FIGURE 21CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES69
5.6.2EUROPE70
FIGURE 22EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)71
5.6.3ASIA PACIFIC72
5.6.3.1Japan72
TABLE 8JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA72
5.6.3.2China73
TABLE 9CHINA: CLASSIFICATION OF MEDICAL DEVICES73
5.6.3.3India74
5.7REIMBURSEMENT SCENARIO75
TABLE 10REIMBURSEMENT CODES FOR VARIOUS PROCEDURES AS OF 202175
5.8VALUE CHAIN ANALYSIS78
FIGURE 23VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE78
5.9SUPPLY CHAIN ANALYSIS79
5.9.1PROMINENT COMPANIES79
5.9.2SMALL & MEDIUM-SIZED ENTERPRISES79
5.9.3END USERS79
FIGURE 24SUPPLY CHAIN ANALYSIS79
5.10ECOSYSTEM ANALYSIS80
5.10.1PARENT MARKET: ORTHOPEDIC IMPLANTS, SURGICAL DEVICES, AND SUPPORT PRODUCTS80
5.11PATENT ANALYSIS81
FIGURE 25PATENT ANALYSIS81
5.12TRADE ANALYSIS81
TABLE 11IMPORT DATA FOR COMPRESSION STOCKINGS (HS CODE 611510), BY COUNTRY, 2017–2021 (USD)81
TABLE 12EXPORT DATA FOR COMPRESSION STOCKINGS (HS CODE 611510), BY COUNTRY, 2017–2021 (USD)82
5.13KEY CONFERENCES & EVENTS, 2022–202382
5.13.1COMPRESSION THERAPY MARKET: LIST OF MAJOR CONFERENCES & EVENTS82
5.14KEY STAKEHOLDERS & BUYING CRITERIA84
5.14.1KEY STAKEHOLDERS IN BUYING PROCESS, BY DISTRIBUTION CHANNEL84
FIGURE 26INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL84
TABLE 13INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL (%)84
5.14.2BUYING CRITERIA85
FIGURE 27KEY BUYING CRITERIA, BY DISTRIBUTION CHANNEL85
TABLE 14KEY BUYING CRITERIA, BY DISTRIBUTION CHANNEL85
6COMPRESSION THERAPY MARKET, BY TECHNIQUE86
6.1INTRODUCTION87
TABLE 15COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)87
6.2STATIC COMPRESSION THERAPY87
6.2.1PROCEDURAL ADVANTAGES OF STATIC COMPRESSION THERAPY TO DRIVE GROWTH87
TABLE 16STATIC COMPRESSION THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)88
6.3DYNAMIC COMPRESSION THERAPY89
6.3.1RISING INCIDENCE OF TARGET CONDITIONS TO SUPPORT MARKET89
TABLE 17DYNAMIC COMPRESSION THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)89
7COMPRESSION THERAPY MARKET, BY PRODUCT90
7.1INTRODUCTION91
TABLE 18COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)91
7.2COMPRESSION BANDAGES91
7.2.1LIMITED AVAILABILITY OF MEDICAL REIMBURSEMENTS FOR VARICOSE VEIN SURGERIES TO RESTRAIN MARKET GROWTH91
TABLE 19COMPRESSION BANDAGES MARKET, BY REGION, 2020–2027 (USD MILLION)92
TABLE 20COMPRESSION BANDAGES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)92
TABLE 21COMPRESSION BANDAGES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)93
TABLE 22COMPRESSION BANDAGES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)93
7.3COMPRESSION WRAPS94
7.3.1RISING GERIATRIC POPULATION AND INCREASING INCIDENCE OF SPORTS INJURIES TO DRIVE MARKET94
TABLE 23COMPRESSION WRAPS MARKET, BY REGION, 2020–2027 (USD MILLION)94
TABLE 24COMPRESSION WRAPS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)94
TABLE 25COMPRESSION WRAPS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)95
TABLE 26COMPRESSION WRAPS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)95
7.4COMPRESSION STOCKINGS96
TABLE 27COMPRESSION STOCKINGS MARKET, BY TYPE, 2020–2027 (USD MILLION)96
TABLE 28COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)97
TABLE 29COMPRESSION STOCKINGS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)97
TABLE 30COMPRESSION STOCKINGS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)98
TABLE 31COMPRESSION STOCKINGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)98
7.4.1CLASS I COMPRESSION STOCKINGS99
7.4.1.1Advantages such as comfort and durability to drive demand for class I stockings99
TABLE 32CLASS I COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)99
7.4.2CLASS II COMPRESSION STOCKINGS100
7.4.2.1Increasing number of lymphedema and DVT patients to fuel demand100
TABLE 33CLASS II COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)100
7.4.3CLASS III COMPRESSION STOCKINGS100
7.4.3.1High level of compression provided to boost adoption of class III stockings100
TABLE 34CLASS III COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)101
7.5COMPRESSION TAPES101
7.5.1ABILITY TO PREVENT FURTHER MUSCLE INJURY TO DRIVE DEMAND FOR COMPRESSION TAPES101
TABLE 35COMPRESSION TAPES MARKET, BY REGION, 2020–2027 (USD MILLION)102
TABLE 36COMPRESSION TAPES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)102
TABLE 37COMPRESSION TAPES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)103
TABLE 38COMPRESSION TAPES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)103
7.6COMPRESSION PUMPS104
TABLE 39COMPRESSION PUMPS MARKET, BY TYPE, 2020–2027 (USD MILLION)105
TABLE 40COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION)105
TABLE 41COMPRESSION PUMPS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)105
TABLE 42COMPRESSION PUMPS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)106
TABLE 43COMPRESSION PUMPS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)106
7.6.1INTERMITTENT PUMPS107
7.6.1.1Availability of wide range of intermittent pumps with varying designs and complexity to boost demand107
TABLE 44INTERMITTENT COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION)107
7.6.2SEQUENTIAL PUMPS107
7.6.2.1Wide usage to prevent development of DVT to boost growth107
TABLE 45SEQUENTIAL COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION)107
7.7COMPRESSION BRACES108
7.7.1RISING NUMBER OF JOINT REPLACEMENT SURGERIES TO SUPPORT MARKET108
TABLE 46COMPRESSION BRACES MARKET, BY REGION, 2020–2027 (USD MILLION)108
TABLE 47COMPRESSION BRACES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)108
TABLE 48COMPRESSION BRACES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)109
TABLE 49COMPRESSION BRACES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)109
7.8OTHER COMPRESSION GARMENTS110
TABLE 50OTHER COMPRESSION GARMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)110
TABLE 51OTHER COMPRESSION GARMENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)110
TABLE 52OTHER COMPRESSION GARMENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)111
TABLE 53OTHER COMPRESSION GARMENTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)111
8COMPRESSION THERAPY MARKET, BY APPLICATION112
8.1INTRODUCTION113
TABLE 54COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027(USD MILLION)113
8.2VARICOSE VEIN TREATMENT113
8.2.1GROWING GLOBAL PREVALENCE OF VARICOSE VEINS TO DRIVE MARKET113
TABLE 55COMPRESSION THERAPY MARKET FOR VARICOSE VEIN TREATMENT, BY REGION, 2020–2027 (USD MILLION)114
8.3DEEP VEIN THROMBOSIS TREATMENT115
8.3.1AVAILABILITY OF ALTERNATIVE TREATMENTS FOR DVT TO LIMIT GROWTH115
TABLE 56COMPRESSION THERAPY MARKET FOR DEEP VEIN THROMBOSIS TREATMENT, BY REGION, 2020–2027 (USD MILLION)116
8.4LYMPHEDEMA TREATMENT116
8.4.1RISING INCIDENCE OF CANCER TO CONTRIBUTE TO GROWTH116
TABLE 57COMPRESSION THERAPY MARKET FOR LYMPHEDEMA TREATMENT, BY REGION, 2020–2027 (USD MILLION)117
8.5LEG ULCER TREATMENT117
8.5.1GROWING DISEASE BURDEN ACROSS MAJOR COUNTRIES TO BOOST MARKET117
TABLE 58COMPRESSION THERAPY MARKET FOR LEG ULCER TREATMENT, BY REGION, 2020–2027 (USD MILLION)118
8.6OTHER APPLICATIONS119
TABLE 59COMPRESSION THERAPY MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)119
9COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL120
9.1INTRODUCTION121
TABLE 60COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)121
9.2PHARMACIES & RETAILERS121
9.2.1RISING ADOPTION OF OFF-THE-SHELF PRODUCTS TO SUPPORT MARKET GROWTH121
TABLE 61COMPRESSION THERAPY MARKET FOR PHARMACIES & RETAILERS, BY REGION, 2020–2027 (USD MILLION)122
9.3E-COMMERCE PLATFORMS122
9.3.1E-COMMERCE PLATFORMS TO REGISTER HIGH CAGR DURING FORECAST PERIOD122
TABLE 62COMPRESSION THERAPY MARKET FOR E-COMMERCE PLATFORMS, BY REGION, 2020–2027 (USD MILLION)123
9.4HOSPITALS & CLINICS123
9.4.1HEALTHCARE INFRASTRUCTURAL IMPROVEMENTS TO BOOST GROWTH123
TABLE 63COMPRESSION THERAPY MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION)124
9.5HOME CARE SETTINGS124
9.5.1GROWING INCLINATION TOWARD HOME HEALTHCARE TO DRIVE MARKET124
TABLE 64COMPRESSION THERAPY MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)125
10COMPRESSION THERAPY MARKET, BY REGION126
10.1INTRODUCTION127
TABLE 65COMPRESSION THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)127
10.2NORTH AMERICA127
FIGURE 28NORTH AMERICA: COMPRESSION THERAPY MARKET SNAPSHOT128
TABLE 66NORTH AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)129
TABLE 67NORTH AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)129
TABLE 68NORTH AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)130
TABLE 69NORTH AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)130
TABLE 70NORTH AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)131
10.2.1US131
10.2.1.1Rising number of sports injuries to drive market growth131
TABLE 71US: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)132
10.2.2CANADA132
10.2.2.1Increasing incidence of target diseases to support growth132
TABLE 72CANADA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)133
10.3EUROPE134
TABLE 73EUROPE: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)134
TABLE 74EUROPE: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)135
TABLE 75EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)135
TABLE 76EUROPE: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)136
TABLE 77EUROPE: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)136
10.3.1GERMANY137
10.3.1.1Inconsistent reimbursement for compression therapy products to restrain market growth137
TABLE 78GERMANY: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)137
10.3.2UK138
10.3.2.1Rising prevalence of lymphedema and DVT to drive market138
TABLE 79UK: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)139
10.3.3FRANCE139
10.3.3.1High incidence of diabetes to drive demand for compression therapy139
TABLE 80FRANCE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)140
10.3.4ITALY140
10.3.4.1Rising awareness about preventive care for musculoskeletal injuries to fuel growth140
TABLE 81ITALY: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)141
10.3.5SPAIN141
10.3.5.1Growing presence of key manufacturers to increase access to compression therapy products141
TABLE 82SPAIN: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)142
10.3.6REST OF EUROPE142
TABLE 83HIP AND KNEE SURGERY PROCEDURES (PER 100,000 PEOPLE) IN EUROPEAN COUNTRIES142
TABLE 84REST OF EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)143
10.4ASIA PACIFIC143
FIGURE 29ASIA PACIFIC: COMPRESSION THERAPY MARKET SNAPSHOT144
TABLE 85ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)145
TABLE 86ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)145
TABLE 87ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)146
TABLE 88ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)146
TABLE 89ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)147
10.4.1JAPAN147
10.4.1.1Japan to dominate Asia Pacific compression therapy market147
TABLE 90JAPAN: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)148
10.4.2CHINA148
10.4.2.1Modernization of healthcare facilities to drive market growth148
TABLE 91CHINA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)149
10.4.3INDIA149
10.4.3.1Growing number of hip & knee surgeries to support market149
TABLE 92INDIA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)150
10.4.4AUSTRALIA150
10.4.4.1Government subsidies related to compression garments for lymphedema patients to promote growth150
TABLE 93AUSTRALIA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)151
10.4.5SOUTH KOREA151
10.4.5.1Increasing number of plastic surgeries to drive demand for compression garments151
TABLE 94SOUTH KOREA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)152
10.4.6REST OF ASIA PACIFIC152
TABLE 95REST OF ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)153
10.5LATIN AMERICA153
TABLE 96LATIN AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)154
TABLE 97LATIN AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)154
TABLE 98LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)155
TABLE 99LATIN AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)155
TABLE 100LATIN AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)156
10.5.1BRAZIL156
10.5.1.1Rising number of cosmetic surgeries to support market156
TABLE 101BRAZIL: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)157
10.5.2MEXICO157
10.5.2.1Lack of reimbursement for bracing products to limit growth157
TABLE 102MEXICO: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)158
10.5.3REST OF LATIN AMERICA158
TABLE 103REST OF LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)159
10.6MIDDLE EAST & AFRICA159
10.6.1UNFAVORABLE REIMBURSEMENT SCENARIO TO HAMPER MARKET GROWTH159
TABLE 104MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)160
TABLE 105MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)160
TABLE 106MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)161
TABLE 107MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)161
11COMPETITIVE LANDSCAPE162
11.1INTRODUCTION162
11.2STRATEGIES ADOPTED BY KEY PLAYERS162
11.2.1OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN COMPRESSION THERAPY MARKET163
TABLE 108STRATEGIES ADOPTED BY KEY COMPRESSION THERAPY PRODUCT MANUFACTURING COMPANIES163
11.3REVENUE SHARE ANALYSIS164
FIGURE 30REVENUE SHARE ANALYSIS OF TOP PLAYERS IN COMPRESSION THERAPY MARKET164
11.4MARKET SHARE ANALYSIS164
FIGURE 31COMPRESSION THERAPY MARKET SHARE, BY KEY PLAYER, 2021165
11.5COMPETITIVE SITUATIONS AND TRENDS165
TABLE 109COMPRESSION THERAPY MARKET: DEGREE OF COMPETITION165
11.6COMPANY EVALUATION QUADRANT166
11.7COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2021)166
11.7.1STARS166
11.7.2EMERGING LEADERS166
11.7.3PERVASIVE PLAYERS166
11.7.4PARTICIPANTS166
FIGURE 32COMPRESSION THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)167
11.8COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (2021)168
11.8.1PROGRESSIVE COMPANIES168
11.8.2STARTING BLOCKS168
11.8.3RESPONSIVE COMPANIES168
11.8.4DYNAMIC COMPANIES168
FIGURE 33COMPRESSION THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) (2021)169
11.9COMPETITIVE BENCHMARKING170
FIGURE 34PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN COMPRESSION THERAPY MARKET170
TABLE 110COMPANY PRODUCT FOOTPRINT170
TABLE 111COMPANY REGIONAL FOOTPRINT171
11.10COMPETITIVE SCENARIO171
11.10.1PRODUCT LAUNCHES171
11.10.2DEALS172
11.10.3OTHER DEVELOPMENTS172
12COMPANY PROFILES173
12.1KEY PLAYERS173
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.13M173
TABLE 1123M: BUSINESS OVERVIEW173
FIGURE 353M: COMPANY SNAPSHOT (2021)174
12.1.2ARJOHUNTLEIGH176
TABLE 113ARJOHUNTLEIGH: BUSINESS OVERVIEW176
FIGURE 36ARJOHUNTLEIGH: COMPANY SNAPSHOT (2021)177
12.1.3BIO COMPRESSION SYSTEMS, INC.179
TABLE 114BIO COMPRESSION SYSTEMS, INC.: BUSINESS OVERVIEW179
12.1.4BSN MEDICAL (A SUBSIDIARY OF ESSITY)180
TABLE 115ESSITY: BUSINESS OVERVIEW180
FIGURE 37ESSITY: COMPANY SNAPSHOT (2021)181
12.1.5CARDINAL HEALTH, INC.183
TABLE 116CARDINAL HEALTH, INC.: BUSINESS OVERVIEW183
FIGURE 38CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022)184
12.1.6CONVATEC INC.186
TABLE 117CONVATEC INC.: BUSINESS OVERVIEW186
FIGURE 39CONVATEC INC.: COMPANY SNAPSHOT (2021)187
12.1.7DJO, LLC (A SUBSIDIARY OF COLFAX CORPORATION)189
TABLE 118DJO, LLC: BUSINESS OVERVIEW189
FIGURE 40COLFAX CORPORATION: COMPANY SNAPSHOT (2021)190
12.1.8JULIUS ZORN GMBH193
TABLE 119JULIUS ZORN GMBH: BUSINESS OVERVIEW193
12.1.9MEDI GMBH & CO. KG195
TABLE 120MEDI GMBH & CO. KG: BUSINESS OVERVIEW195
12.1.10PAUL HARTMANN AG198
TABLE 121PAUL HARTMANN AG: BUSINESS OVERVIEW198
FIGURE 41PAUL HARTMANN AG: COMPANY SNAPSHOT (2021)199
12.1.11SANYLEG S.R.L.201
TABLE 122SANYLEG S.R.L.: BUSINESS OVERVIEW201
12.1.12SIGVARIS GROUP204
TABLE 123SIGVARIS GROUP: BUSINESS OVERVIEW204
12.1.13SMITH & NEPHEW PLC206
TABLE 124SMITH & NEPHEW PLC: BUSINESS OVERVIEW206
FIGURE 42SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2021)207
12.1.14TACTILE SYSTEMS TECHNOLOGY, INC. (“TACTILE MEDICAL”)209
TABLE 125TACTILE MEDICAL: BUSINESS OVERVIEW209
FIGURE 43TACTILE MEDICAL: COMPANY SNAPSHOT (2021)210
12.1.15MEGO AFEK LTD.212
TABLE 126MEGO AFEK LTD.: BUSINESS OVERVIEW212
12.2OTHER PLAYERS214
12.2.1MEDLINE INDUSTRIES, LP214
12.2.2GOTTFRIED MEDICAL, INC.215
12.2.3THERMOTEK, INC.216
12.2.4BAUERFEIND AG217
12.2.5OFA BAMBERG GMBH218
12.2.6ACI MEDICAL, LLC218
12.2.7AIROS MEDICAL INC.219
12.2.8BARCELCOM TÊXTEIS, S.A.220
12.2.9CIZETA MEDICALI S.P.A.221
12.2.10BÖSL MEDIZINTECHNIK222
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13APPENDIX223
13.1DISCUSSION GUIDE223
13.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL228
13.3CUSTOMIZATION OPTIONS230
13.4RELATED REPORTS230
13.5AUTHOR DETAILS231
“Compression pumps segment is expected to witness the highest growth rate during the forecast period”
On the basis of product, the compression therapy market is segmented into compression bandages, compression wraps, compression stockings, compression tapes, compression pumps, compression braces, and other compression garments. Compression pumps segment is anticipated to register the highest CAGR during the forecast period. Factors such as the increasing incidence of cancer, the rising prevalence of chronic venous diseases, and the growing number of hip and knee surgeries are expected to drive the growth of the compression pumps market during the forecast period.
“varicose vein treatment segment to capture the largest market share or compression therapy market in 2021, by application
On the basis of application, the compression therapy market is segmented into varicose vein treatment, deep vein thrombosis treatment, lymphedema treatment, leg ulcer treatment, and other applications. The varicose vein treatment segment accounted for the largest share the compression therapy market in 2021. The large share of this segment is mainly driven by the increasing prevalence of varicose veins, the high preference for compression therapy as the first line of treatment for varicose veins,
” The Asia Pacific market is expected to grow at the highest CAGR during the forecast period”
The global compression therapy market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa). During the forecast period of Asia Pacific market is estimated to grow at the highest CAGR owing to the increase in patient population with diabetes, large geriatric patient pool, growing prevalence of orthopedic disorders and improved healthcare infrastructure in the region.
A breakdown of the primary participants referred to for this report is provided below:
•By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
•By Designation: C-level–10%, Director-level–14%, and Others–76%
•By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%
The major players operating in the compression therapy market are DJO, Inc. (US), BSN Medical (US), medi GmbH & Co. KG (Germany), Tactile Medical (US), SIGVARIS (Switzerland), Paul Hartmann AG (Germany), Sanyleg S.r.l. (Italy), 3M (US), ConvaTec Inc. (US), ArjoHuntleigh (Sweden), Julius Zorn GmbH (Germany), Bio Compression Systems, Inc. (US), Cardinal Health, Inc. (US), Smith & Nephew Plc (UK) and Mego Afek Ltd. (Israel).
Research Coverage
This report studies the compression therapy market based on product, technique, application, distribution channel, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the compression therapy market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the compression therapy market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the compression therapy market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
1INTRODUCTION26
1.1STUDY OBJECTIVES26
1.2MARKET DEFINITION26
1.2.1INCLUSIONS & EXCLUSIONS27
1.3STUDY SCOPE28
1.3.1MARKETS COVERED28
1.3.2YEARS CONSIDERED29
1.4CURRENCY29
TABLE 1STANDARD CURRENCY CONVERSION RATES30
1.5LIMITATIONS30
1.6KEY MARKET STAKEHOLDERS30
1.7SUMMARY OF CHANGES30
2RESEARCH METHODOLOGY32
2.1RESEARCH DATA32
FIGURE 1RESEARCH DESIGN32
2.1.1SECONDARY DATA33
2.1.1.1Indicative list of secondary sources34
2.1.2PRIMARY DATA35
2.1.2.1Key data from primary sources36
FIGURE 2BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION36
2.2MARKET ESTIMATION METHODOLOGY37
FIGURE 3RESEARCH METHODOLOGY: HYPOTHESIS BUILDING37
2.2.1REVENUE MAPPING-BASED MARKET ESTIMATION38
2.2.2SALES/DISTRIBUTION CHANNEL-BASED MARKET ESTIMATION39
FIGURE 4MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL COMPRESSION THERAPY MARKET39
FIGURE 5CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS40
2.3RECESSION IMPACT41
2.3.1IMPACT OF RECESSION ON COMPRESSION THERAPY MARKET41
2.4DATA TRIANGULATION42
FIGURE 6DATA TRIANGULATION METHODOLOGY42
2.5RESEARCH ASSUMPTIONS43
2.6RESEARCH LIMITATIONS43
3EXECUTIVE SUMMARY44
FIGURE 7COMPRESSION THERAPY MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)44
FIGURE 8COMPRESSION THERAPY MARKET SHARE, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)45
FIGURE 9COMPRESSION THERAPY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)45
FIGURE 10COMPRESSION THERAPY MARKET SHARE, BY DISTRIBUTION CHANNEL, 2022 VS. 202746
FIGURE 11GEOGRAPHICAL SNAPSHOT OF COMPRESSION THERAPY MARKET47
4PREMIUM INSIGHTS48
4.1COMPRESSION THERAPY MARKET OVERVIEW48
FIGURE 12GROWING INCIDENCE OF SPORTS INJURIES AND FAVORABLE CLINICAL EVIDENCE TO DRIVE MARKET GROWTH48
4.2COMPRESSION THERAPY MARKET SHARE, BY PRODUCT, 2022 VS. 2027 (USD MILLION)49
FIGURE 13COMPRESSION PUMPS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD49
4.3COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)50
FIGURE 14STATIC COMPRESSION THERAPY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD50
4.4COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 (USD MILLION)51
FIGURE 15HOSPITALS & CLINICS TO ACCOUNT FOR LARGEST SHARE OF COMPRESSION THERAPY MARKET IN 202751
4.5COMPRESSION THERAPY MARKET, BY REGION, 2020–202752
FIGURE 16ASIA PACIFIC TO WITNESS FASTEST GROWTH IN MARKET DURING FORECAST PERIOD52
5MARKET OVERVIEW53
5.1INTRODUCTION53
5.2MARKET DYNAMICS53
FIGURE 17COMPRESSION THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES53
5.2.1DRIVERS54
5.2.1.1Large target patient population54
FIGURE 18GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 205055
5.2.1.2Growing incidence of sports injuries and accidents55
FIGURE 19EUROPE: ROAD DEATHS PER MILLION INHABITANTS, BY COUNTRY, 202156
5.2.1.3Increasing number of orthopedic procedures56
5.2.1.4Greater product affordability and market availability57
5.2.1.5Clinical evidence favoring adoption of compression therapy for management of target conditions57
5.2.2RESTRAINTS58
5.2.2.1Lack of universally accepted standards for compression products58
5.2.2.2Low patient compliance with compression garments58
FIGURE 20REASONS FOR NON-COMPLIANCE TO COMPRESSION THERAPY59
5.2.3OPPORTUNITIES59
5.2.3.1Growth potential offered by emerging markets59
5.2.3.2Growing patient awareness regarding benefits of compression therapy60
5.2.3.3Increased sales of off-the-shelf and online products60
5.2.4CHALLENGES60
5.2.4.1Significant adoption of alternative therapies for specific target indications60
5.2.4.2Increasing pricing pressure on market players61
5.3PORTER’S FIVE FORCES ANALYSIS61
5.3.1OVERVIEW61
TABLE 2COMPRESSION THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS62
5.3.2BARGAINING POWER OF BUYERS62
5.3.3BARGAINING POWER OF SUPPLIERS62
5.3.4THREAT FROM NEW ENTRANTS62
5.3.5THREAT FROM SUBSTITUTES62
5.3.6INTENSITY OF COMPETITIVE RIVALRY63
5.4PRICING TREND ANALYSIS63
5.4.1AVERAGE SELLING PRICE, BY PRODUCT63
TABLE 3AVERAGE PRICE OF KEY COMPRESSION THERAPY PRODUCTS, 2021 (USD)63
5.4.2AVERAGE SELLING PRICE, BY REGION64
TABLE 4REGIONAL PRICING ANALYSIS OF KEY COMPRESSION THERAPY PRODUCTS, 2021 (USD)64
5.5TECHNOLOGY ANALYSIS64
5.5.1WIRELESS BIOSENSORS64
5.5.2GARMENT MANUFACTURING TECHNOLOGIES65
5.6REGULATORY ANALYSIS66
5.6.1NORTH AMERICA66
5.6.1.1US66
TABLE 5US FDA: MEDICAL DEVICE CLASSIFICATION67
TABLE 6US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS67
5.6.1.2Canada68
TABLE 7CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS68
FIGURE 21CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES69
5.6.2EUROPE70
FIGURE 22EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)71
5.6.3ASIA PACIFIC72
5.6.3.1Japan72
TABLE 8JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA72
5.6.3.2China73
TABLE 9CHINA: CLASSIFICATION OF MEDICAL DEVICES73
5.6.3.3India74
5.7REIMBURSEMENT SCENARIO75
TABLE 10REIMBURSEMENT CODES FOR VARIOUS PROCEDURES AS OF 202175
5.8VALUE CHAIN ANALYSIS78
FIGURE 23VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE78
5.9SUPPLY CHAIN ANALYSIS79
5.9.1PROMINENT COMPANIES79
5.9.2SMALL & MEDIUM-SIZED ENTERPRISES79
5.9.3END USERS79
FIGURE 24SUPPLY CHAIN ANALYSIS79
5.10ECOSYSTEM ANALYSIS80
5.10.1PARENT MARKET: ORTHOPEDIC IMPLANTS, SURGICAL DEVICES, AND SUPPORT PRODUCTS80
5.11PATENT ANALYSIS81
FIGURE 25PATENT ANALYSIS81
5.12TRADE ANALYSIS81
TABLE 11IMPORT DATA FOR COMPRESSION STOCKINGS (HS CODE 611510), BY COUNTRY, 2017–2021 (USD)81
TABLE 12EXPORT DATA FOR COMPRESSION STOCKINGS (HS CODE 611510), BY COUNTRY, 2017–2021 (USD)82
5.13KEY CONFERENCES & EVENTS, 2022–202382
5.13.1COMPRESSION THERAPY MARKET: LIST OF MAJOR CONFERENCES & EVENTS82
5.14KEY STAKEHOLDERS & BUYING CRITERIA84
5.14.1KEY STAKEHOLDERS IN BUYING PROCESS, BY DISTRIBUTION CHANNEL84
FIGURE 26INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL84
TABLE 13INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL (%)84
5.14.2BUYING CRITERIA85
FIGURE 27KEY BUYING CRITERIA, BY DISTRIBUTION CHANNEL85
TABLE 14KEY BUYING CRITERIA, BY DISTRIBUTION CHANNEL85
6COMPRESSION THERAPY MARKET, BY TECHNIQUE86
6.1INTRODUCTION87
TABLE 15COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)87
6.2STATIC COMPRESSION THERAPY87
6.2.1PROCEDURAL ADVANTAGES OF STATIC COMPRESSION THERAPY TO DRIVE GROWTH87
TABLE 16STATIC COMPRESSION THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)88
6.3DYNAMIC COMPRESSION THERAPY89
6.3.1RISING INCIDENCE OF TARGET CONDITIONS TO SUPPORT MARKET89
TABLE 17DYNAMIC COMPRESSION THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)89
7COMPRESSION THERAPY MARKET, BY PRODUCT90
7.1INTRODUCTION91
TABLE 18COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)91
7.2COMPRESSION BANDAGES91
7.2.1LIMITED AVAILABILITY OF MEDICAL REIMBURSEMENTS FOR VARICOSE VEIN SURGERIES TO RESTRAIN MARKET GROWTH91
TABLE 19COMPRESSION BANDAGES MARKET, BY REGION, 2020–2027 (USD MILLION)92
TABLE 20COMPRESSION BANDAGES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)92
TABLE 21COMPRESSION BANDAGES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)93
TABLE 22COMPRESSION BANDAGES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)93
7.3COMPRESSION WRAPS94
7.3.1RISING GERIATRIC POPULATION AND INCREASING INCIDENCE OF SPORTS INJURIES TO DRIVE MARKET94
TABLE 23COMPRESSION WRAPS MARKET, BY REGION, 2020–2027 (USD MILLION)94
TABLE 24COMPRESSION WRAPS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)94
TABLE 25COMPRESSION WRAPS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)95
TABLE 26COMPRESSION WRAPS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)95
7.4COMPRESSION STOCKINGS96
TABLE 27COMPRESSION STOCKINGS MARKET, BY TYPE, 2020–2027 (USD MILLION)96
TABLE 28COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)97
TABLE 29COMPRESSION STOCKINGS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)97
TABLE 30COMPRESSION STOCKINGS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)98
TABLE 31COMPRESSION STOCKINGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)98
7.4.1CLASS I COMPRESSION STOCKINGS99
7.4.1.1Advantages such as comfort and durability to drive demand for class I stockings99
TABLE 32CLASS I COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)99
7.4.2CLASS II COMPRESSION STOCKINGS100
7.4.2.1Increasing number of lymphedema and DVT patients to fuel demand100
TABLE 33CLASS II COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)100
7.4.3CLASS III COMPRESSION STOCKINGS100
7.4.3.1High level of compression provided to boost adoption of class III stockings100
TABLE 34CLASS III COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)101
7.5COMPRESSION TAPES101
7.5.1ABILITY TO PREVENT FURTHER MUSCLE INJURY TO DRIVE DEMAND FOR COMPRESSION TAPES101
TABLE 35COMPRESSION TAPES MARKET, BY REGION, 2020–2027 (USD MILLION)102
TABLE 36COMPRESSION TAPES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)102
TABLE 37COMPRESSION TAPES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)103
TABLE 38COMPRESSION TAPES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)103
7.6COMPRESSION PUMPS104
TABLE 39COMPRESSION PUMPS MARKET, BY TYPE, 2020–2027 (USD MILLION)105
TABLE 40COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION)105
TABLE 41COMPRESSION PUMPS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)105
TABLE 42COMPRESSION PUMPS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)106
TABLE 43COMPRESSION PUMPS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)106
7.6.1INTERMITTENT PUMPS107
7.6.1.1Availability of wide range of intermittent pumps with varying designs and complexity to boost demand107
TABLE 44INTERMITTENT COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION)107
7.6.2SEQUENTIAL PUMPS107
7.6.2.1Wide usage to prevent development of DVT to boost growth107
TABLE 45SEQUENTIAL COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION)107
7.7COMPRESSION BRACES108
7.7.1RISING NUMBER OF JOINT REPLACEMENT SURGERIES TO SUPPORT MARKET108
TABLE 46COMPRESSION BRACES MARKET, BY REGION, 2020–2027 (USD MILLION)108
TABLE 47COMPRESSION BRACES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)108
TABLE 48COMPRESSION BRACES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)109
TABLE 49COMPRESSION BRACES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)109
7.8OTHER COMPRESSION GARMENTS110
TABLE 50OTHER COMPRESSION GARMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)110
TABLE 51OTHER COMPRESSION GARMENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)110
TABLE 52OTHER COMPRESSION GARMENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)111
TABLE 53OTHER COMPRESSION GARMENTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)111
8COMPRESSION THERAPY MARKET, BY APPLICATION112
8.1INTRODUCTION113
TABLE 54COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027(USD MILLION)113
8.2VARICOSE VEIN TREATMENT113
8.2.1GROWING GLOBAL PREVALENCE OF VARICOSE VEINS TO DRIVE MARKET113
TABLE 55COMPRESSION THERAPY MARKET FOR VARICOSE VEIN TREATMENT, BY REGION, 2020–2027 (USD MILLION)114
8.3DEEP VEIN THROMBOSIS TREATMENT115
8.3.1AVAILABILITY OF ALTERNATIVE TREATMENTS FOR DVT TO LIMIT GROWTH115
TABLE 56COMPRESSION THERAPY MARKET FOR DEEP VEIN THROMBOSIS TREATMENT, BY REGION, 2020–2027 (USD MILLION)116
8.4LYMPHEDEMA TREATMENT116
8.4.1RISING INCIDENCE OF CANCER TO CONTRIBUTE TO GROWTH116
TABLE 57COMPRESSION THERAPY MARKET FOR LYMPHEDEMA TREATMENT, BY REGION, 2020–2027 (USD MILLION)117
8.5LEG ULCER TREATMENT117
8.5.1GROWING DISEASE BURDEN ACROSS MAJOR COUNTRIES TO BOOST MARKET117
TABLE 58COMPRESSION THERAPY MARKET FOR LEG ULCER TREATMENT, BY REGION, 2020–2027 (USD MILLION)118
8.6OTHER APPLICATIONS119
TABLE 59COMPRESSION THERAPY MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)119
9COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL120
9.1INTRODUCTION121
TABLE 60COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)121
9.2PHARMACIES & RETAILERS121
9.2.1RISING ADOPTION OF OFF-THE-SHELF PRODUCTS TO SUPPORT MARKET GROWTH121
TABLE 61COMPRESSION THERAPY MARKET FOR PHARMACIES & RETAILERS, BY REGION, 2020–2027 (USD MILLION)122
9.3E-COMMERCE PLATFORMS122
9.3.1E-COMMERCE PLATFORMS TO REGISTER HIGH CAGR DURING FORECAST PERIOD122
TABLE 62COMPRESSION THERAPY MARKET FOR E-COMMERCE PLATFORMS, BY REGION, 2020–2027 (USD MILLION)123
9.4HOSPITALS & CLINICS123
9.4.1HEALTHCARE INFRASTRUCTURAL IMPROVEMENTS TO BOOST GROWTH123
TABLE 63COMPRESSION THERAPY MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION)124
9.5HOME CARE SETTINGS124
9.5.1GROWING INCLINATION TOWARD HOME HEALTHCARE TO DRIVE MARKET124
TABLE 64COMPRESSION THERAPY MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)125
10COMPRESSION THERAPY MARKET, BY REGION126
10.1INTRODUCTION127
TABLE 65COMPRESSION THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)127
10.2NORTH AMERICA127
FIGURE 28NORTH AMERICA: COMPRESSION THERAPY MARKET SNAPSHOT128
TABLE 66NORTH AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)129
TABLE 67NORTH AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)129
TABLE 68NORTH AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)130
TABLE 69NORTH AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)130
TABLE 70NORTH AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)131
10.2.1US131
10.2.1.1Rising number of sports injuries to drive market growth131
TABLE 71US: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)132
10.2.2CANADA132
10.2.2.1Increasing incidence of target diseases to support growth132
TABLE 72CANADA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)133
10.3EUROPE134
TABLE 73EUROPE: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)134
TABLE 74EUROPE: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)135
TABLE 75EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)135
TABLE 76EUROPE: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)136
TABLE 77EUROPE: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)136
10.3.1GERMANY137
10.3.1.1Inconsistent reimbursement for compression therapy products to restrain market growth137
TABLE 78GERMANY: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)137
10.3.2UK138
10.3.2.1Rising prevalence of lymphedema and DVT to drive market138
TABLE 79UK: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)139
10.3.3FRANCE139
10.3.3.1High incidence of diabetes to drive demand for compression therapy139
TABLE 80FRANCE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)140
10.3.4ITALY140
10.3.4.1Rising awareness about preventive care for musculoskeletal injuries to fuel growth140
TABLE 81ITALY: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)141
10.3.5SPAIN141
10.3.5.1Growing presence of key manufacturers to increase access to compression therapy products141
TABLE 82SPAIN: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)142
10.3.6REST OF EUROPE142
TABLE 83HIP AND KNEE SURGERY PROCEDURES (PER 100,000 PEOPLE) IN EUROPEAN COUNTRIES142
TABLE 84REST OF EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)143
10.4ASIA PACIFIC143
FIGURE 29ASIA PACIFIC: COMPRESSION THERAPY MARKET SNAPSHOT144
TABLE 85ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)145
TABLE 86ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)145
TABLE 87ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)146
TABLE 88ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)146
TABLE 89ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)147
10.4.1JAPAN147
10.4.1.1Japan to dominate Asia Pacific compression therapy market147
TABLE 90JAPAN: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)148
10.4.2CHINA148
10.4.2.1Modernization of healthcare facilities to drive market growth148
TABLE 91CHINA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)149
10.4.3INDIA149
10.4.3.1Growing number of hip & knee surgeries to support market149
TABLE 92INDIA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)150
10.4.4AUSTRALIA150
10.4.4.1Government subsidies related to compression garments for lymphedema patients to promote growth150
TABLE 93AUSTRALIA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)151
10.4.5SOUTH KOREA151
10.4.5.1Increasing number of plastic surgeries to drive demand for compression garments151
TABLE 94SOUTH KOREA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)152
10.4.6REST OF ASIA PACIFIC152
TABLE 95REST OF ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)153
10.5LATIN AMERICA153
TABLE 96LATIN AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)154
TABLE 97LATIN AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)154
TABLE 98LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)155
TABLE 99LATIN AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)155
TABLE 100LATIN AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)156
10.5.1BRAZIL156
10.5.1.1Rising number of cosmetic surgeries to support market156
TABLE 101BRAZIL: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)157
10.5.2MEXICO157
10.5.2.1Lack of reimbursement for bracing products to limit growth157
TABLE 102MEXICO: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)158
10.5.3REST OF LATIN AMERICA158
TABLE 103REST OF LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)159
10.6MIDDLE EAST & AFRICA159
10.6.1UNFAVORABLE REIMBURSEMENT SCENARIO TO HAMPER MARKET GROWTH159
TABLE 104MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)160
TABLE 105MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)160
TABLE 106MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)161
TABLE 107MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)161
11COMPETITIVE LANDSCAPE162
11.1INTRODUCTION162
11.2STRATEGIES ADOPTED BY KEY PLAYERS162
11.2.1OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN COMPRESSION THERAPY MARKET163
TABLE 108STRATEGIES ADOPTED BY KEY COMPRESSION THERAPY PRODUCT MANUFACTURING COMPANIES163
11.3REVENUE SHARE ANALYSIS164
FIGURE 30REVENUE SHARE ANALYSIS OF TOP PLAYERS IN COMPRESSION THERAPY MARKET164
11.4MARKET SHARE ANALYSIS164
FIGURE 31COMPRESSION THERAPY MARKET SHARE, BY KEY PLAYER, 2021165
11.5COMPETITIVE SITUATIONS AND TRENDS165
TABLE 109COMPRESSION THERAPY MARKET: DEGREE OF COMPETITION165
11.6COMPANY EVALUATION QUADRANT166
11.7COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2021)166
11.7.1STARS166
11.7.2EMERGING LEADERS166
11.7.3PERVASIVE PLAYERS166
11.7.4PARTICIPANTS166
FIGURE 32COMPRESSION THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)167
11.8COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (2021)168
11.8.1PROGRESSIVE COMPANIES168
11.8.2STARTING BLOCKS168
11.8.3RESPONSIVE COMPANIES168
11.8.4DYNAMIC COMPANIES168
FIGURE 33COMPRESSION THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) (2021)169
11.9COMPETITIVE BENCHMARKING170
FIGURE 34PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN COMPRESSION THERAPY MARKET170
TABLE 110COMPANY PRODUCT FOOTPRINT170
TABLE 111COMPANY REGIONAL FOOTPRINT171
11.10COMPETITIVE SCENARIO171
11.10.1PRODUCT LAUNCHES171
11.10.2DEALS172
11.10.3OTHER DEVELOPMENTS172
12COMPANY PROFILES173
12.1KEY PLAYERS173
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.13M173
TABLE 1123M: BUSINESS OVERVIEW173
FIGURE 353M: COMPANY SNAPSHOT (2021)174
12.1.2ARJOHUNTLEIGH176
TABLE 113ARJOHUNTLEIGH: BUSINESS OVERVIEW176
FIGURE 36ARJOHUNTLEIGH: COMPANY SNAPSHOT (2021)177
12.1.3BIO COMPRESSION SYSTEMS, INC.179
TABLE 114BIO COMPRESSION SYSTEMS, INC.: BUSINESS OVERVIEW179
12.1.4BSN MEDICAL (A SUBSIDIARY OF ESSITY)180
TABLE 115ESSITY: BUSINESS OVERVIEW180
FIGURE 37ESSITY: COMPANY SNAPSHOT (2021)181
12.1.5CARDINAL HEALTH, INC.183
TABLE 116CARDINAL HEALTH, INC.: BUSINESS OVERVIEW183
FIGURE 38CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022)184
12.1.6CONVATEC INC.186
TABLE 117CONVATEC INC.: BUSINESS OVERVIEW186
FIGURE 39CONVATEC INC.: COMPANY SNAPSHOT (2021)187
12.1.7DJO, LLC (A SUBSIDIARY OF COLFAX CORPORATION)189
TABLE 118DJO, LLC: BUSINESS OVERVIEW189
FIGURE 40COLFAX CORPORATION: COMPANY SNAPSHOT (2021)190
12.1.8JULIUS ZORN GMBH193
TABLE 119JULIUS ZORN GMBH: BUSINESS OVERVIEW193
12.1.9MEDI GMBH & CO. KG195
TABLE 120MEDI GMBH & CO. KG: BUSINESS OVERVIEW195
12.1.10PAUL HARTMANN AG198
TABLE 121PAUL HARTMANN AG: BUSINESS OVERVIEW198
FIGURE 41PAUL HARTMANN AG: COMPANY SNAPSHOT (2021)199
12.1.11SANYLEG S.R.L.201
TABLE 122SANYLEG S.R.L.: BUSINESS OVERVIEW201
12.1.12SIGVARIS GROUP204
TABLE 123SIGVARIS GROUP: BUSINESS OVERVIEW204
12.1.13SMITH & NEPHEW PLC206
TABLE 124SMITH & NEPHEW PLC: BUSINESS OVERVIEW206
FIGURE 42SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2021)207
12.1.14TACTILE SYSTEMS TECHNOLOGY, INC. (“TACTILE MEDICAL”)209
TABLE 125TACTILE MEDICAL: BUSINESS OVERVIEW209
FIGURE 43TACTILE MEDICAL: COMPANY SNAPSHOT (2021)210
12.1.15MEGO AFEK LTD.212
TABLE 126MEGO AFEK LTD.: BUSINESS OVERVIEW212
12.2OTHER PLAYERS214
12.2.1MEDLINE INDUSTRIES, LP214
12.2.2GOTTFRIED MEDICAL, INC.215
12.2.3THERMOTEK, INC.216
12.2.4BAUERFEIND AG217
12.2.5OFA BAMBERG GMBH218
12.2.6ACI MEDICAL, LLC218
12.2.7AIROS MEDICAL INC.219
12.2.8BARCELCOM TÊXTEIS, S.A.220
12.2.9CIZETA MEDICALI S.P.A.221
12.2.10BÖSL MEDIZINTECHNIK222
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13APPENDIX223
13.1DISCUSSION GUIDE223
13.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL228
13.3CUSTOMIZATION OPTIONS230
13.4RELATED REPORTS230
13.5AUTHOR DETAILS231
Related Report
